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Abstract: Oleanolic acid (3β-hydroxy-olean-12-en-28-oic acid; OA-01), a pentacyclic triterpene, exhibit a wide range of 
pharmacological ad biological activities. We have isolated oleanolic acid from methanolic extract of Periploca aphylla, 
collected from surroundings of Karachi in the month of February. Furthermore, four known and two new C-28 amino 
acid conjugates of oleanolic acid were prepared to explore potential of these compounds on HCCs and one breast cancer 
cell line. Cytotoxic effects revealed that as compare to parent compound (OA-01), two derivatives OA-04 (p<0.0001) 
and OA-06 (p<0.01) showed significantly increased /higher inhibition rates.  
 




Pentacyclic triterpenoids of lupane, ursane and oleanane 
series are reported to posses high pharmacological 
potential for different cancer cell lines (Silva et al., 2012). 
Prominent of these are betulinic acid, ursolic acid and 
oleanolic acid (Cichewicz et al., 2004, He X et al., 2007, 
Jie Li et al., 2002, Jie Liu., 2005, Laszczyk., 2009, Liu et 
al., 2012, Meng et al., 2009, Patlolla et al., 2012, 
Petronelli et al., 2009, Silva et al., 2012, Tae et al., 2011, 
Wang et al., 2009). C-28 amino acid conjugates of 
betulinic acid (Jeong et al., 1999) and ursolic acid have 
exhibited promising activity against human melanoma. 
Hence, despite striking structural similarity of oleanolic 
acid with betulinic acid and ursolic acid its C-28 amino 
acid conjugates have been not studied against a number of 
cancer cell lines with an exception of N-[(3β)-3-
(acetyloxy)-28-oxoolean-12-en-28-yl]-glycine methyl 
ester (Lu et al., 2007). Although, oleanolic acid 
derivatives obtained through modification at C-28 
carboxylic moiety displayed promising inhibition against 
human Hepatocellular carcinoma cell line (HepG2) and 
colon cancer cell line (Col-02) (Tae et al., 2011, Jie Li et 
al., 2002). 
 
Oleanolic acid (3β-hydroxy-olean-12-en-28-oic acid; OA) 
is a naturally occurring pentacyclic triterpenoid found in 
more than 1600 species (Yeung et al., 2010). Literature 
demonstrates that oleanolic acid and its derivatives are 
reported to exhibit a wide range of biological and 
pharmacological properties including anti-inflammatory 
(Lee et al., 2013), antitumor (Lu et al., 2007), Anti HIV 
(Zhu et al., 2001), antioxidant (Gao et al., 2009), 
cardiotonic (Somova et al., 2004), diuretic (Jadhav et al., 
2010) and hepatoprotective properties (Jeong., 1999). 
 
Further structural conversion of C-3 hydroxyl group in to 
acetoxy, oxo or hydroxy imino group showed strong 
cytotoxic activity as compare to oleanolic acid 
(Bednarczyk-Cwynar et al., 2012). Anticancer activities 
of oleanolic acid and its derivatives are reported against 
four human liver cancer cell lines HepG2, Hep3B, HUH7 
and HA22T (Yan et al., 2010), Non-Small Cell lung 
cancer cell lines A459 and H460 (Lu cio et al., 2011), 
human colon carcinoma cell line HCT15 (Jie Li et al., 
2002), ovarian carcinomas IGROV1 and breast cancer 




Oleanolic acid was isolated from Periploca aphylla 
applying classical separation techniques in four steps 
shown in Scheme-1(vide experimental). Periploca aphylla 
is shrub common in southern region of Pakistan (Zhu et 
al., 2001). The aerial parts (leaves and stem bark) of 
Periploca aphylla were collected from surroundings of 
Karachi region during January and February 2009. 
 
Structural modifications of organic compounds often 
enhance biological activities of secondary metabolites. 
For this reason six amino acid conjugates of oleanolic 
acid, have been synthesized including N-[(3β)-hydroxy-
12-en-28-oxoolean-28-yl]-glycine methyl ester (OA-2), 
N-[(3β)-hydroxy-12-en-28-oxoolean-28-yl]-L-cysteine *Corresponding author: e-mail: firdousilyas@yahoo.com 
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methyl ester (OA-3), N-[(3β)-hydroxy-12-en-28-
oxoolean-28-yl]- L-leucine methyl ester (OA-4), N-[(3β)-
hydroxy-12-en-28-oxoolean-28-yl]-L-phenyl alanine 
methyl ester (OA-5), N-[(3β)-hydroxy-12-en-28-
oxoolean-28-yl] ]-L-alanine ethyl ester (OA-6), N-[(3β)-
hydroxy-12-en-28-oxoolean-28-yl] ]-L-tryptophane 
methyl ester (OA-7) were prepared out of which two 
(OA-3 and OA-7) are hitherto unreported. 
 
Scheme 1: Schematic diagaram of isolation 
 
The amide bond between OA-1 and amino acid esters was 
achieved by applying most common strategy of amide 
formation i.e. carbodiimide protocol (Gao et al., 2009). In 
a general procedure 1 equivalent of OA-1 in 
dichloromethane (CH2Cl2), 2 equivalent of respective 
amino acid ester, 1 equivalent of dicyclocarbidiimide 
(DCC) and 0.5 equivalent of dimethylaminopyridine 
(DMAP) were stirred at room temperature for 2 hours. 
After usual workup respective amino acid derivatives 




Scheme 2: Synthesis of amino acid conjugates of 
Oleanolic acid (OA-01) 
 
The structures of synthesized compounds were confirmed 
through ESI, IR and 1H-NMR spectroscopic data and 
comparison with reported literature (Somova et al., 2004, 
Jadhav et al., 2010). Cytotoxic evaluation of these 
compounds against eight hepatocellular carcinoma (HCC) 
cell lines including HUH7, Hep3B, HepG2, SNU449, 
Mahlavue, PLC, SNU387 and SNU475 and one breast 
cancer line MCF7 was carried out using Sulforhdamine B 
(SRB) method. Results displayed superior activity of all 
synthesized compounds over parent compound against 
aforementioned cell lines. This behavior suggests further 
investigation of structurally modified oleanolic acid 





In recent study, a total of six OA derivatives were 
screened for their cytotoxic effect on one breast cancer 
and eight HCC cells by SRB technique as described in 
experimental part. Trial drugs OA-02, OA-03, OA-04, 
OA-05, OA-06, OA-07 and parent compound OA-01 
were introduced in two different (50uM and 10uM) 
concentrations in triplicate for each sample. 
 
Out of six OA derivatives, OA-04 (100%) and OA-06 
(100%) showed higher inhibitory effects on both HUH7 
and MCF7 cell than parent compound OA-01 (41% and 
73%) at 50uM concentration. Similarly, as presented in 
table 1; comparatively significant increased of inhibitory 
effects was recorded at 10uM of both OA-04 and OA-06. 
 
Based on primary screening results (fig. 1), OA-04 
containing valine as amino acid conjugate was found to 
be the most potent with 100% growth attenuation at 50uM 
concentration on HUH7 and MCF7 cells; and 
significantly (p<0.0001) high inhibitory effect at 10uM on 
MCF7 cells. Therefore, most potent trial drug OA-04 was 
further subjected for systematic primary screening with 
eight HCC and one-breast cancer cell lines to examine the 
% inhibition at 10uM concentration. (fig. 2). 
 
As per above-mentioned findings, MCF7 and HUH7Cells 
were used. 2000-2500 cells were cultured in each well of 
96 well-plate and incubated for 24 hours. After 24hours, 
cells were treated with OA-04 drug at different 
concentrations in triplicates ranging from 10uM to 
0.313uM; for controls up to 0.1% DMSO final 
concentration was maintained with respective media for 
each cell line; camptothecin as a positive drug indicator 
was also used in triplicate at 5uM concentration. The IC50 
values against on both MCF7 and HUH7 cell lines were 
determined against each drug concentration. 
Camptothecin showed 95%-100% growth attenuation at 
5uM concentration on both cell lines. 
 
As presented in inhibition curve in fig. 3, IC50 value of 
OA-04 was calculated as 18.9uM and 43.8uM on MCF7 
and HUH7 cells respectively;; indicating that this drug 
might have comparatively higher therapeutic index on 
MCF7 cells than other trial drugs of the study. 
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In short, the study elaborates isolation of oleanolic acid in 
large amounts from Periploca aphylla using very simple, 
time saving and comparatively inexpensive strategy. 
 
Finally, we devised comparatively inexpensive, rapid and 
simple isolation protocol for synthesis of bulk amount of 
oleanolic acid from aerial parts of Periploca aphylla. 
Secondly, six C-28 amino acid conjugates of oleanolic 
acid were prepared to explore the role of structural 
manipulations and potential effects of these compounds 
on HCCs and one breast cancer cell line. Cytotoxic effects 
revealed that as compare to parent compound (OA-1), 
three amino acid conjugate derivatives OA-04, OA-06 
and OA-07 showed significantly high inhibition rates at 
10uM; indicating enhanced cytotoxic efficiency of 
structurally manipulated derivate. 
 
MATERIALS AND METHODS 
 
General: All reagents were purchased from Sigma–
Aldrich and Merck and were used without further 
purification. Technical grade solvents were used for 
Table 1: Comparison of inhibition rates (%) 
 
Compound Code 
Inhibition rates (%) 
HUH7 MCF7 
50µM (±SD) 10µM (±SD) 50µM (±SD) 10µM (±SD) 
OA-01 40,98 (0,215) 29,11 (0,261) 72,91 (0,004) 16,4 (0,039) 
OA-02 0 0 40,81 (0,012) 0 
OA-03 12,6 (0,046) 0 27,63 (0,028) 0 
OA-04 100 (0,001) 33,42 (0,187) 100 (0,001) 66,54* (0,009) 
OA-05 89,81 (0,024) 11,49 (0,192) 97,44 (0,002) 2,04 (0,008) 
OA-06 99,8 (0,004) 44,58* (0,115) 100 (0,001) 30,01* (0,017) 
OA-07 93,43 (0,011) 25,99 (0,049) 99,21 (0,001) 30,27* (0,029) 
*Statistically significant (p<0.01) increased inhibition rates than parent compound (OA-01) Values are means of three experiments 
after exposure of 72 hours of trial drugs. Negative values approximated to zero growth attenuation. 
 
 
Fig. 1: Primary screening results 
Each inhibition bar represents mean of three experiments. Inhibition rates were Calculated using following formulae; % 
inhibition=100- (Average OD of samples) X100/Average OD of Control) 
Synthesis and characterization of amino acid conjugates of oleanolic acid and their in vitro cytotoxic 
Pak. J. Pharm. Sci., Vol.27, No.5(Special), September 2014, pp.1491-1496 1494
chromatography and distilled prior to use. Thin layer 
chromatography was performed on M-N ALUGRAM 
(registered Germany) Silica gel/ UV 254 sheets, and 
detection of spots was made by UV light and/or iodine 
vapors. Column chromatography was performed using 
silica gel 70-230-mesh.  
 
Extraction and Isolation of Oleanolic acid 
The fresh, un-dried and uncrushed aerial parts including 
leaves and stem (100 kg) were repeatedly extracted with 
methanol five times at room temperature. The solvent 
from the combined extract was evaporated in vacuum and 
the concentrated into gummy extract. The gummy plant 
extract (10 Kg) was stirred with water and Ethylacetate 
(EtOAc) resulting in three layers, aquous layer, EtOAc 
soluble layer and solid particles sandwiched between two 
solvents. 
 
Fig. 2: OA-04 Response at 10uM concentration on cell 
lines (n=9) 
*Camptothecin (CPT) used as positive control with 5uM 
concentration on each cell line. **DMSO upto 0.1% of 
final concentration in respective media used as negative 
Control. Each bar represents average of three values with 
the exposure of 72 hours of trial drug. 
 
Mr. Jan Alam of Botany department identified it and a G. 
H. # 85609 was given. A voucher specimen has been 
deposited in the herbarium of the same department. The 
fresh, un-dried and uncrushed leaves (100kg) were 
repeatedly extracted with methanol (five times) at room 
temperature. The solvent from the combined extract was 
evaporated in vacuum and the concentrated into gummy 
extract. The gummy plant extract (vide experimental) 
from aerial parts of the plant was stirred with water and 
Ethylacetate (EtOAc) resulting in three layers, aquous 
layer, EtOAc soluble layer and solid particles sandwiched 
between two solvents. The EtOAc part was evaporated to 
obtain gummy mass was obtained, which after dissolving 
in minimum amount of EtOAc treated with excessive 
amount of hexane resulting in precipitation. The hexane 
insoluble part (precipitates, 250g) was subjected for 
charcoaling in CHCl3-MeOH (9.5:0.5) yielded <95% pure 
crystalline oleanolic acid (OA-1) identified through 
comparison TLC with authentic sample and comparison 
with spectroscopic data reported literature. 
 
General procedure for the preparation of Amides from 
amino acids 
To a solution of oleanolic acid (1 mole) in 
dichloromethane, dicyclohexyl carbodiimide (DCC, 1 
mole), 4-dimethyl amino pyridine (DMAP, 0.5 mole) and 
amino acid esters (1 mole) were added, the resulting 
mixture was stirred at room temperature for two hour. 
After completion of reaction 50 ml of ethyl acetate was 
added and filter, to the filterate add 20 ml of water and 
separate the organic layer. Again add 20 ml of water and 
separate the organic layer. Dry with anhydrous sodium 
sulfate and evaporate. 
 
Fig. 3: Inhibition Curve with IC50 values of MCF7 and 
HUH7 
In order to determine IC50 values, Modelling laboratory 
(MLAB), and interactive mathematical modelling 
software is used (Civilized Software, Inc.; Gary Knott; 
Revision Date: Oct. 8, 1996). Each point represents 
average of three values with the exposure of 72 hours of 
trial drug and compared with negative control. The bar 




methyl ester (OA-3)  
Yield: 90%; Amorphous solid, IR (KBr): υmax=3401, 
2931, 2858, 2550, 1740, 1646, 1507, 1451, 1388, 1207 
cm-1; 1H NMR (300MHz, CDCl3) δ: 2.93 (1H, dd, J=13.1, 
3.6 Hz, H-18), 3.23 (1H, dd, J=12.3, 5.0 Hz, H-3), 5.40 
(1H, s, H-12), 5.08 (1H, t, J=6.8 Hz, H-2'), 2.83 (1H, d, J 
=6.8 Hz, H-2'); HRMS-ESI calcd for C35H57O4NS 
(M+H)+ 588.4087, found 588.3954.  
 
N-[(3β)-hydroxy-12-en-28-oxoolean-28-yl] ]-L- 
tryptophane methyl ester (OA-7)  
Yield: 91%; Amorphous solid; IR (KBr): υmax =3401, 
2931, 2858, 1740, 1646, 1507, 1451, 1388, 1207 cm-1; 1H 
NMR (300MHz, CDCl3) δ: 2.93 (1H, dd, J=13.1, 3.6 Hz, 
H-18), 3.23 (1H, dd, J=12.3, 5.0 Hz, H-3), 3.750 (2H, s, 
H-2'), 5.40 (1H, s, H-12), 7.071 (1H, s, H-10'), 7.107 (1H, 
t, J=7.2 Hz, H-7'), 7.174 (1H, t, J=7.2 Hz, H-6'), 7.311 
(1H, d, J=8.0 Hz, H-8'), 7.591 (1H, d, J=7.6 Hz, H-5'); 
HRMS-ESI calcd for C42H60O4N2 (M+H)+ 657.4631, 
found 657.4569.  
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Stock solution preparation 
All stock solutions were prepared in 100% DMSO with a 
concentration of 20mM. Further dilutions were made up 
to 0.1% of DMSO with the help of respective media used 
for each cell line. 
 
Cell lines 
Eight hepatocellular carcinoma (HCC) cell lines including 
HUH7, Hep3B, HepG2, Snu449, Mahlavue, PLC, Snu387 
and Snu475. While, one breast cancer line MCF7 was 
also used for primary screening. The cell lines were 
provided by MÖ (Mehmet Özturk) group, Department of 
Molecular Biology and Genetics, Bilkent University, 
Ankara, Turkey. 
 
Cytotoxicity screening protocol 
Sulforhdamine B (SRB) is an aminoxanthene dye with 
two phenolic groups, responsible to attach with the cell 
proteins in slightly acidic environment, therefore 10% 
TCA is used to fix the attached cells by maintaining 
acidic condition; cells become decolorized and detached 
in basic phase by using 10mM trisma base. Absorbance in 
terms of optical Density (OD) for each sample is 
measured using microplate reader in between SRB dye 
reference range. The SRB assay is non-destructive, very 
stable and colorimetric screening protocol, was first 
carried out by Skehan et al [21-22]. In current study, SRB 
method was used for screening. One hepatocellular 
carcinoma (HCC) cell line HUH7 and one breast cancer 
line MCF7 were used for initial screening of trial drugs. 
For both HUH7 and MCF7 cell lines, 2000 cells/ well 
were cultured in 96 well plate in incubator at 37oC with 5 
% CO2 in complete medium (DMEM, 10% FBS, 1% 
NEA, 1% L-Glutamine and 1% P/S) and wait for 24 
hours. All stock solutions were prepared in 100% DMSO 
with a concentration of 20mM. Further dilutions were 
made with the help of respective media used for each cell 
line. After 24hours, all trial drugs were introduced in two 
different (50uM and 10uM) concentrations in triplicate 
for each sample and plates were further incubated for next 
72 hours. After 72 hours, media were discarded and cells 
were washed once by using 1XPBS. For fixation, 50ul of 
ice cold 10% TCA was added into each well and kept in 
dark at 4oC for one hour. After fixation, the TCA was 
removed by tapping and plates were washed 4-5 X with ∼ 
200 µl dH2O. Plates were left over night for drying under 
hood. Finally, 50ul of 0.4% sulforhodamine B (SRB) in 
1% acetic acid solution was added to each well and left at 
room temperature for 10 min. SRB was removed and the 
plates washed 4-5 times with 1% acetic acid before air 
drying. Bound SRB was solubilized with 100ul of 10 mM 
un-buffered chilled Tris-base solution and plates were left 
on a plate shaker for at least 1-2 min. Absorbance was 
recorded using µ-Quant microplate reader with a wave 
length range of 405-515nm. The test OD values were 
defined as the absorbance of each sample. Mean values 
were determined and standerd deviation was found 
satisfactory ranging in between 0.001 to 0.25 in all 
respective samples from triplicates wells which was 
calculated automatically using Excel 7.0 software for 
Windows 2007.  
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